Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy. - Kuerer,H.M.; Newman,L.A.; Smith,T.L. (J Clin Oncol, 1999)